Temozolomide Capsules IP is an oral anticancer medicine used to treat certain brain tumors by damaging the DNA of cancer cells and slowing their growth.
Key Benefits
- Used in the treatment of certain brain tumors
- Helps slow the growth and multiplication of cancer cells
- Damages cancer cell DNA
- Can be used as part of combination treatment with radiotherapy in appropriate patients
- Supports anticancer treatment under specialist supervision
How It Works
Temozolomide is converted in the body into an active compound that adds methyl groups to DNA. This DNA damage interferes with cancer cell replication and can lead to cancer cell death, helping slow tumor growth.
Common Side Effects
- Nausea and vomiting
- Headache
- Fatigue or weakness
- Constipation
- Loss of appetite
- Seizures
- Low blood cell counts
- Increased risk of infection
Important Information
Temozolomide should be used under the supervision of an oncologist. Regular blood tests are required to monitor blood cell counts because the medicine can cause significant bone marrow suppression. Antiemetic medicines may be prescribed to help control nausea and vomiting. Temozolomide can cause serious fetal harm, so appropriate pregnancy precautions should be discussed with a healthcare professional. Do not change or stop treatment without medical advice.